ENTITY
Ligand Pharmaceuticals

Ligand Pharmaceuticals (LGND US)

13
Analysis
Health Care • United States
Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers, as well as cardiovascular, inflammatory, and skin diseases.
more
Company Presentation • 06 Nov 2025 21:30
Company Presentation • 08 May 2025 20:30
Company Presentation • 27 Feb 2025 21:30
Company Presentation • 07 Nov 2024 21:30
Company Presentation • 07 Aug 2024 04:30
x